Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.
Kim, Seung Tae
Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy. [electronic resource] - Oncology 2010 - 363-9 p. digital
Publication Type: Journal Article
1423-0232
10.1159/000322498 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Cisplatin--therapeutic use
Disease-Free Survival
Esophageal Neoplasms--drug therapy
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Patient Selection
Prognosis
Retrospective Studies
Salvage Therapy
Treatment Outcome
Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy. [electronic resource] - Oncology 2010 - 363-9 p. digital
Publication Type: Journal Article
1423-0232
10.1159/000322498 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Cisplatin--therapeutic use
Disease-Free Survival
Esophageal Neoplasms--drug therapy
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Patient Selection
Prognosis
Retrospective Studies
Salvage Therapy
Treatment Outcome